SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jessica Liu, Hwai-I Yang, Mei-Hsuan Lee, Chin-Lan Jen, Richard Batrla-Utermann, Sheng-Nan Lu, Li-Yu Wang, San-Lin You, Chien-Jen Chen, Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression, Hepatology, 2016, 63, 5
  2. 2
    Yuan-Hung Kuo, Kuo-Ching Chang, Jing-Houng Wang, Pei-Shan Tsai, Shu-Feng Hung, Chao-Hung Hung, Sheng-Nan Lu, Changing serum levels of quantitative hepatitis B surface antigen and hepatitis B virus DNA in hepatitis B virus surface antigen carriers: A follow-up study of an elderly cohort, The Kaohsiung Journal of Medical Sciences, 2015, 31, 2, 102

    CrossRef

  3. 3
    Weiwei Liu, Yao Hu, Yannan Yang, Tingting Hu, Xinyu Wang, Comparison of two immunoassays for quantification of hepatitis B surface antigen in Chinese patients with concomitant hepatitis B surface antigen and hepatitis B surface antibodies, Archives of Virology, 2015, 160, 1, 191

    CrossRef

  4. 4
    Da-wu Zeng, Yue-yong Zhu, Qian Huang, Jie-min Zhang, Yin-lian Wu, Jing Dong, Jia-ji Jiang, Yu-rui Liu, Hepatitis B surface antigen in late hepatitis B infection, Journal of Medical Virology, 2015, 87, 3
  5. 5
    Kwang Hyun Chung, Won Kim, Byeong Gwan Kim, Ho-Young Lee, Eunhyo Jin, Yuri Cho, Ji Yeon Seo, Hwi Young Kim, Yong Jin Jung, Ji Won Kim, Ji Bong Jeong, Kook Lae Lee, Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay, Gut and Liver, 2015, 9, 5

    CrossRef

  6. 6
    Wei-Ren Liu, Meng-Xin Tian, Lei Jin, Liu-Xiao Yang, Zhen-Bin Ding, Ying-Hao Shen, Yuan-Fei Peng, Jian Zhou, Shuang-Jian Qiu, Zhi Dai, Jia Fan, Ying-Hong Shi, High Levels of Hepatitis B Surface Antigen are Associated with Poorer Survival and Early Recurrence of Hepatocellular Carcinoma in Patients with Low Hepatitis B Viral Loads, Annals of Surgical Oncology, 2015, 22, 3, 843

    CrossRef

  7. 7
    Zhaoxia Tan, Maoshi Li, Xuemei Kuang, Yu Tang, Yi Fan, Guohong Deng, Yuming Wang, Dengming He, Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection, Journal of Clinical Virology, 2014, 59, 4, 228

    CrossRef

  8. 8
    Shuhei Nishiguchi, Comparison of each HBs antigen assay and it^|^apos;s clinical utility, Kanzo, 2014, 55, 6, 310

    CrossRef

  9. 9
    Yuecheng Yu, Jinlin Hou, Masao Omata, Yue Wang, Lanjuan Li, Loss of HBsAg and antiviral treatment: from basics to clinical significance, Hepatology International, 2014, 8, 1, 39

    CrossRef

  10. 10
    Elisa Burdino, Tina Ruggiero, Alex Proietti, Maria Grazia Milia, Antonella Olivero, Gian Paolo Caviglia, Milena Marietti, Mario Rizzetto, Antonina Smedile, Valeria Ghisetti, Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XL Murex HBsAg Quant: Correlation with the ARCHITECT quantitative assays, Journal of Clinical Virology, 2014, 60, 4, 341

    CrossRef

  11. 11
    Chih-Lin Lin, Jia-Horng Kao, Hepatitis B viral factors and treatment responses in chronic hepatitis B, Journal of the Formosan Medical Association, 2013, 112, 6, 302

    CrossRef

  12. You have free access to this content12
    L. Boglione, A. D'Avolio, G. Cariti, M. G. Milia, M. Simiele, A. Nicolò, V. Ghisetti, G. Di Perri, Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes, Journal of Viral Hepatitis, 2013, 20, 4
  13. 13
    Hyun Ji Lee, Shine Young Kim, Sun Min Lee, Jeong Heo, Hyung Hoi Kim, Chulhun L. Chang, Eun Yup Lee, Han Chul Son, Elecsys Hepatitis B Surface Antigen Quantitative Assay: Performance Evaluation and Correlation with Hepatitis B Virus DNA during 96 Weeks of Follow-up in Chronic Hepatitis B Patients, Annals of Laboratory Medicine, 2012, 32, 6, 420

    CrossRef

  14. 14
    Avnish K Seth, HBsAg Quantification in Clinical Practice, Journal of Clinical and Experimental Hepatology, 2012, 2, 1, 75

    CrossRef

  15. 15
    Chun-Hui Yan, Cheng-Yu Zhao, Hai Ding, Ya-Qin Peng, Peng-Yuan Jin, Ling Yan, Hui Zhuang, Tong Li, Hepatitis B virus basal core promoter mutations A1762T/G1764A are associated with genotype C and a low serum HBsAg level in chronically-infected HBeAg-positive Chinese patients, Antiviral Research, 2012, 96, 2, 108

    CrossRef

  16. 16
    Shannan R. Tujios, William M. Lee, New advances in chronic hepatitis B, Current Opinion in Gastroenterology, 2012, 28, 3, 193

    CrossRef

  17. 17
    Rami Moucari, Raymond Sayegh, Patrick Marcellin, Update on the Role of Quantitative HBsAg and HBeAg Monitoring during Peginterferon Therapy, Current Hepatitis Reports, 2012, 11, 2, 75

    CrossRef

  18. 18
    Annabelle Servant-Delmas, Mélanie Mercier-Darty, Thoai Duong Ly, Françoise Wind, Chakib Alloui, Camille Sureau, Syria Laperche, Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples, Journal of Clinical Virology, 2012, 53, 4, 338

    CrossRef

  19. 19
    Maximilian Lee, Emmet B. Keeffe, Hepatitis B: Modern End Points of Treatment and the Specter of Viral Resistance, Gastroenterology Clinics of North America, 2011, 40, 3, 495

    CrossRef

  20. 20
    Chih-Lin Lin, Jia-Horng Kao, Recent advances in the treatment of chronic hepatitis B, Expert Opinion on Pharmacotherapy, 2011, 12, 13, 2025

    CrossRef